<?xml version="1.0" ?>
<document id="653c1744be45d5e3ba3e9fb48edf6c6997976324">
  <chunk id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c0" text="Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications">
    <entity charOffset="0-8" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c0.e0" ontology_id="DOID_3298" text="Vaccinia" type="disease"/>
  </chunk>
  <chunk id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1" text="The LC16m8 strain of vaccinia virus, the active ingredient in the Japanese smallpox vaccine, was derived from the Lister/Elstree strain. LC16m8 is replication-competent and has been administered to over 100,000 infants and 3,000 adults with no serious adverse reactions. Despite this outstanding safety profile, the occurrence of spontaneously-generated large plaque-forming virulent LC16m8 revertants following passage in cell culture is a major drawback. We identified the gene responsible for the reversion and deleted the gene (B5R) from LC16m8 to derive LC16m8Δ. LC16m8∆ is non-pathogenic in immunodeficient severe combined immunodeficiency (SCID) mice, genetically-stable and does not reverse to a large-plaque phenotype upon passage in cell culture, even under conditions in which most LC16m8 populations are replaced by revertants. Moreover, LC16m8∆ is &gt;500-fold more effective than the non-replicating vaccinia virus (VV), Modified Vaccinia Ankara (MVA), at inducing murine immune responses against pathogenic VV. LC16m8∆, which expresses the SIV gag gene, also induced anti-Gag CD8 + T-cells more efficiently than MVA and another non-replicating VV, Dairen I minute-pock variants (DIs). Moreover, LC16m8∆ expressing HIV-1 Env in combination with a Sendai virus vector induced the production of anti-Env antibodies and CD8 + T-cells. Thus, the safety and efficacy of LC16m8∆ mean that it represents an outstanding platform for the development of human vaccine vectors.">
    <entity charOffset="21-29" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e0" ontology_id="DOID_3298" text="vaccinia" type="disease"/>
    <entity charOffset="75-83" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e1" ontology_id="DOID_8736" text="smallpox" type="disease"/>
    <entity charOffset="613-645" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e2" ontology_id="DOID_627" text="severe combined immunodeficiency" type="disease"/>
    <entity charOffset="620-645" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e3" ontology_id="DOID_628" text="combined immunodeficiency" type="disease"/>
    <entity charOffset="647-651" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e4" ontology_id="DOID_627" text="SCID" type="disease"/>
    <entity charOffset="911-919" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e5" ontology_id="DOID_3298" text="vaccinia" type="disease"/>
    <entity charOffset="941-949" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e6" ontology_id="DOID_3298" text="Vaccinia" type="disease"/>
    <entity charOffset="1056-1059" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e7" ontology_id="CHEBI_143889" text="gag" type="chemical"/>
    <entity charOffset="1124-1127" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e8" ontology_id="CHEBI_25351" text="MVA" type="chemical"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e0" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e7" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p0" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e0" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e8" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p1" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e1" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e7" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p2" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e1" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e8" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p3" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e2" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e7" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p4" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e2" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e8" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p5" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e3" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e7" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p6" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e3" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e8" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p7" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e4" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e7" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p8" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e4" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e8" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p9" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e5" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e7" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p10" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e5" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e8" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p11" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e6" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e7" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p12" relation="true"/>
    <pair e1="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e6" e2="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.e8" id="653c1744be45d5e3ba3e9fb48edf6c6997976324.c1.p13" relation="true"/>
  </chunk>
</document>
